{"id":404150,"date":"2025-07-18T01:05:00","date_gmt":"2025-07-17T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=404150"},"modified":"2025-06-26T18:02:19","modified_gmt":"2025-06-26T16:02:19","slug":"fadiga-causada-por-injeccoes-na-esclerose-multipla-recorrente-remitente","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/fadiga-causada-por-injeccoes-na-esclerose-multipla-recorrente-remitente\/","title":{"rendered":"Fadiga causada por injec\u00e7\u00f5es na esclerose m\u00faltipla recorrente-remitente"},"content":{"rendered":"\n<p><strong>A fadiga da inje\u00e7\u00e3o e a avers\u00e3o \u00e0 agulha est\u00e3o entre as barreiras subestimadas no tratamento de doentes com esclerose m\u00faltipla recorrente-remitente (EMRR). As an\u00e1lises actuais do mundo real mostram uma persist\u00eancia significativamente menor das terapias de base inject\u00e1veis em compara\u00e7\u00e3o com as formas orais de tratamento. Ao mesmo tempo, um estudo de coorte prospetivo mostra que as barreiras psicol\u00f3gicas, como o medo das injec\u00e7\u00f5es, s\u00e3o um fator determinante independente das doses n\u00e3o administradas. Neste contexto, a identifica\u00e7\u00e3o precoce dos doentes de risco correspondente e a considera\u00e7\u00e3o de alternativas de tratamento oral s\u00e3o essenciais para garantir a ades\u00e3o ao tratamento a longo prazo e, consequentemente, o sucesso do tratamento.   <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Ffadiga-causada-por-injeccoes-na-esclerose-multipla-recorrente-remitente%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>A fadiga da inje\u00e7\u00e3o e a avers\u00e3o \u00e0 agulha est\u00e3o entre as barreiras subestimadas no tratamento de doentes com esclerose m\u00faltipla recorrente-remitente (EMRR). As an\u00e1lises actuais do mundo real mostram&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Ffadiga-causada-por-injeccoes-na-esclerose-multipla-recorrente-remitente%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":404151,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Ades\u00e3o \u00e0 terap\u00eautica e sele\u00e7\u00e3o de doentes","footnotes":""},"category":[11521,11524,11374,11551],"tags":[21142,12325],"powerkit_post_featured":[],"class_list":["post-404150","post","type-post","status-publish","format-standard","has-post-thumbnail","category-estudos","category-formacao-continua","category-neurologia-pt-pt","category-rx-pt","tag-aderencia-terapeutica","tag-esclerose-multipla","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-12 06:53:22","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":404144,"slug":"fatiga-por-inyeccion-en-la-esclerosis-multiple-remitente-recurrente","post_title":"Fatiga por inyecci\u00f3n en la esclerosis m\u00faltiple remitente-recurrente","href":"https:\/\/medizinonline.com\/es\/fatiga-por-inyeccion-en-la-esclerosis-multiple-remitente-recurrente\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/404150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=404150"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/404150\/revisions"}],"predecessor-version":[{"id":404153,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/404150\/revisions\/404153"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/404151"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=404150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=404150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=404150"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=404150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}